Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Pheochromocytoma 3Paraganglioma 3Neuroendocrine Tumors 2Meningioma 2von Hippel-Lindau Disease 1Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Metastatic Neuroendocrine Prostate Cancer 1Kidney Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Ganglioneuroma 1Ganglioneuroblastoma 1Carcinoma, Neuroendocrine 1Adenocarcinoma, Follicular 1

Interventions

lutetium Lu 177 dotatate 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiosurgery 3gallium Ga 68 dotatate 2abemaciclib 2Ga(III)-DOTATOC 2Bevacizumab 2ribociclib 1regorafenib 1pembrolizumab 1olaparib 1neratinib 1capivasertib 1cabozantinib 1brigatinib 1X-Rays 1Watchful Waiting 1Tablets 1Surveys and Questionnaires 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Protons 1Proton Therapy 1Photons 1Observation 1ONC206 1Nivolumab 1Mental Status and Dementia Tests 1Lysine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Meningioma × gallium Ga 68 dotatate × 90 days × Clear all
NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting
30 enrolled
CNS

Meningioma

NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Mayo Clinic

Phase 2 Recruiting
42 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡